Your browser doesn't support javascript.
loading
MYORG Mutation Heterozygosity Is Associated With Brain Calcification.
Chen, You; Cen, Zhidong; Chen, Xinhui; Wang, Haotian; Chen, Si; Yang, Dehao; Fu, Feng; Wang, Lebo; Liu, Peng; Wu, Hongwei; Zheng, Xiaosheng; Xie, Fei; Ouyang, Zhiyuan; Zhang, Yun; Zhou, Yongji; Huang, Xuerong; Wang, Feng; Huang, Guangsu; An, Hongwei; Liang, Yubing; Hong, Weijun; Wang, Anli; Huang, Shuangling; Chen, Wenhai; Yin, Lili; Yang, Yan; Huang, Huayun; Zeng, Ruxin; Zhao, Na; Jiang, Biao; Zhang, Baorong; Luo, Wei.
Afiliación
  • Chen Y; Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Cen Z; Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Chen X; Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Wang H; Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Chen S; Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Yang D; Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Fu F; Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Wang L; Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Liu P; Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Wu H; Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Zheng X; Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Xie F; Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Ouyang Z; Department of Neurology, Zhuji People's Hospital of Zhejiang Province, Shaoxing, Zhejiang, China.
  • Zhang Y; Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Zhou Y; Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Huang X; Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Wang F; Department of Neurology, Lishui People's Hospital, Lishui, Zhejiang, China.
  • Huang G; Department of Intensive Care Unit, Zhejiang Hospital, Hangzhou, Zhejiang, China.
  • An H; Department of Neurology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Liang Y; Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Hong W; Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Wang A; Department of Neurology, Hangzhou Geriatric Hospital (Hangzhou First People's Hospital Chengbei branch), Hangzhou, Zhejiang, China.
  • Huang S; Department of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Chen W; Department of Neurology, Taizhou Hospital, Taizhou, Zhejiang, China.
  • Yin L; Department of Neurology, Liuzhou People's Hospital, Liuzhou, Guangxi, China.
  • Yang Y; Department of Neurology, Liuzhou Traditional Chinese Medical Hospital, Liuzhou, Guangxi, China.
  • Huang H; Department of Neurology, Liuzhou Traditional Chinese Medical Hospital, Liuzhou, Guangxi, China.
  • Zeng R; Department of Neurology, Taizhou Enze Medical Center (Group) Enze Hospital, Taizhou, Zhejiang, China.
  • Zhao N; Department of Neurology, Pujiang County People's Hospital, Jinhua, Zhejiang, China.
  • Jiang B; Department of Neurology, Liping Hospital of Chinese Traditional Medicine, Liping, Guizhou, China.
  • Zhang B; Department of Neurology, Liping County People's Hospital, Liping, Guizhou, China.
  • Luo W; Department of Neurology, Sanmen People's Hospital, Taizhou, Zhejiang, China.
Mov Disord ; 35(4): 679-686, 2020 04.
Article en En | MEDLINE | ID: mdl-31951047
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Encefalopatías / Glicósido Hidrolasas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mov Disord Asunto de la revista: NEUROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Encefalopatías / Glicósido Hidrolasas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mov Disord Asunto de la revista: NEUROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: China